Swin Ratnayake
Data Scientist | AI Engineer
Talent
Hamilton, OntarioMember since March 3, 2025
·
Hire this person
Send a job offer directly to this candidate
About
Experienced in AI-driven solutions, LLMs, NLP, and computer vision across healthcare, robotics,
recruitment and digital marketing. Skilled in Python, R, SQL, and cloud platforms, with a strong focus on optimizing AI infrastructure and automating processes. Passionate about solving complex problems with data and machine learning.
Experience
HYPE Invention Pty Ltd (2023 - Present)
- AI-Powered Photographer Robot: Developed an autonomous photography AI using Florence-2, OpenAI CLIP, and OpenCV for scene analysis, object detection, and aesthetic evaluation. Integrated AI with robotics for precise camera control.
- AI-Assisted Patient Management System: Fine-tuned Mistral NeMo with medical data, outperforming GPT-4o in domain accuracy. Deployed on Google Cloud Vertex AI and Kubernetes, reducing infrastructure costs by 88% ($35K → $4K/month).
Medfuture Healthcare Pty Ltd (2021 - 2023)
- Built SQL pipelines and Power BI dashboards for healthcare analytics.
- Developed machine learning models to automate recruitment, improving candidate matching by 80%.
- Conducted digital marketing analysis to optimize campaign performance.
Lanka Hospitals PLC (2018 - 2021)
- Performed microbiological & molecular-biological lab analyses.
Key Skills:
Computer Vision, NLP, Machine Learning, AI Model Optimization, SQL, Python, Power BI, Cloud AI (Google Cloud, Kubernetes), Robotics AI.Education
Education:
- Master of Science in Data Science – Cardiff Metropolitan University, UK (2023)
- Bachelor of Science in Biological Science – State University of New York at Oswego, USA (2018)
Key Project:
Lung Cancer Prediction Web App (Master’s Thesis – ML & Healthcare AI)- Developed a machine learning-based web app for lung cancer risk prediction using Flask and scikit-learn, deployed on AWS.
- Trained linear regression and random forest models on a dataset of 535 individuals, achieving 97% AUC and 0.76 R², outperforming benchmarks.
- Enhanced early detection and clinical decision-making for high-risk patients.